Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2025-12-24 @ 6:41 PM
NCT ID:
NCT03309657
Eligibility Criteria:
Inclusion Criteria:
Patients with any infection requiring treatment with ceftolozane/tazobactam and who have met the following criteria:
* Age \>18 years
* The presence of an indwelling external ventricular drain (EVD) or requiring EVD insertion due to obstructive hydrocephalus/subarachnoid haemorrhage
Exclusion Criteria:
* Known or suspected allergy to penicillins and cephalosporins
* Pregnancy
* Receiving renal replacement therapy
* Glomerular filtration rate less than 10 mL/min
* Receiving piperacillin/tazobactam or having received piperacillin/tazobactam in the past 7 days before enrolment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03309657
Study Brief:
Protocol Section:
NCT03309657